Related Experiment Video
Updated: Jun 13, 2026
09:09
High Throughput, Real-time, Dual-readout Testing of Intracellular Antimicrobial Activity and Eukaryotic Cell Cytotoxicity
Published on: November 16, 2016
Azithromycin decreases crevicular fluid volume and mediator content
W Ho1, T Eubank, B Leblebicioglu
1Division of Periodontology, College of Dentistry, 305 West 12th Avenue.
Journal of Dental Research
|April 20, 2010
Summary
Azithromycin, an antibiotic, reduced gingival crevicular fluid (GCF) volume and key inflammatory mediators in healthy volunteers. These findings suggest azithromycin possesses anti-inflammatory effects on gingival tissues.
Area of Science:
- Periodontology
- Pharmacology
- Immunology
Background:
- Azithromycin is known to enhance root planing response and exert anti-inflammatory effects in chronic lung disease.
- This suggests a potential role for azithromycin in modulating inflammatory processes in other tissues.
Purpose of the Study:
- To investigate the hypothesis that azithromycin inhibits inflammatory mediator production in gingiva.
- To determine if azithromycin reduces gingival crevicular fluid (GCF) volume.
Main Methods:
- Ten periodontally healthy volunteers received azithromycin for 48 hours.
- GCF samples were collected from 12 maxillary interproximal sites at baseline and days 2, 4, 7, and 14.
- Samples were analyzed for inflammatory mediators including IL-1beta, IL-8, TNF-alpha, and VEGF.
Main Results:
- Azithromycin treatment led to a significant decrease in GCF volume on days 2 through 7 (P < 0.05).
- A transient reduction in IL-1beta, IL-8, TNF-alpha, and VEGF levels was observed.
- IL-6 and IL-10 were not detected in the GCF samples.
Conclusions:
- Azithromycin demonstrates anti-inflammatory effects in gingival tissues.
- The findings suggest azithromycin can reduce gingival inflammation, evidenced by decreased GCF volume and inflammatory mediator levels.
- Further research may explore azithromycin's therapeutic potential in periodontal conditions.
Related Concept Videos
01:19Ascites
DefinitionAscites is the buildup of fluid inside the peritoneal cavity. It occurs when fluid moves out of the vascular system faster than the peritoneal lymphatics can remove it. This fluid shift is most commonly seen in liver cirrhosis but can also appear in several other systemic disorders.EtiologyCirrhosis remains the leading cause of ascites. Other conditions that can contribute include:Heart failureConstrictive pericarditisAbdominal cancersNephrotic syndromeSevere protein–calorie...
01:28Pleural Effusion II: Symptoms and Management
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
01:15Antihypertensive Drugs: Thiazide-Class Diuretics
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
01:18Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
01:14Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...